Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
226-240 of 2977 results
Genomic Health reveals analytical validation study results of Oncotype SEQ liquid biopsy mutation panel
Genomic Health has announced results from its successfully completed analytical validation study of Oncotype SEQ Liquid Select, which demonstrated that this liquid biopsy mutation panel is highly sensitive, specific and reproducible.
Diagnostics > In Vitro Diagnostics > News
HiberGene introduces new product to diagnose meningococcal bacteria presence
By MDBR Staff Writer
HiberGene Diagnostics has introduced a new product, which the company claims can be used to quickly and correctly diagnose the presence of meningococcal bacteria.
Diagnostics > In Vitro Diagnostics > News
BioGX’s influenza A, B and RSV assay gets CE-IVD marking for use on BD MAX system
By MDBR Staff Writer
US-based BioGX has obtained CE-IVD marking for its Flu A, Flu B, RSV automated test for use on Becton, Dickinson and Company’s (BD) MAX system.
Diagnostics > In Vitro Diagnostics > News
BioVentures raises $87m to invest in medical technology enterprises
By MDBR Staff Writer
BioVentures Investors, an investment firm focused on the commercial development of advanced technology in life sciences and healthcare, has raised $87m to invest in breakthrough medical technology.
Diagnostics > In Vitro Diagnostics > News
Agilent Technologies showcases innovative laboratory solutions at analytica China 2016
Agilent Technologies will showcase its latest innovations at analytica China 2016, the leading Chinese exhibition for laboratory technology, analysis, biotechnology and diagnostics, in Shanghai, Oct. 10–12, 2016.
Diagnostics > In Vitro Diagnostics > News
Interpace Diagnostics launches new molecular product for pancreatic cysts
Interpace Diagnostics Group has completed its initial launch of PanDNA, a new product that stratifies patients' risk of developing pancreatic cancer based on three specific molecular criteria.
Diagnostics > In Vitro Diagnostics > News
Almac Diagnostics partners with ArcherDX
Almac Group's Diagnostics business has announced its partnership with ArcherDX to provide FusionPlex and VariantPlex NGS assays as part of their CDx partnership solutions.
Diagnostics > In Vitro Diagnostics > News
Shore Capital Partners divests ClearPath Diagnostics
Shore Capital Partners has announced the sale of ClearPath Diagnostics, a provider of laboratory diagnostic services in the Northeastern US to Laboratory Corporation of America Holdings, the world’s leading healthcare diagnostics company.
Diagnostics > In Vitro Diagnostics > News
FDA approves Siemens’ hand-held portable coagulation analyzer
By MDBR Staff Writer
Siemens Healthineers has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its hand-held portable coagulation analyzer.
Diagnostics > In Vitro Diagnostics > News
SouthGenetics to distribute MDxHealth's Prostate Cancer assay in Central/South America
SouthGenetics has agreed to distribute MDxHealth's SelectMDx for Prostate Cancer assay in select countries in Central and South America.
Diagnostics > In Vitro Diagnostics > News
Intuitive Surgical, Fosun Pharma establish JV to develop lung cancer diagnostic tools in China
Intuitive Surgical and Shanghai Fosun Pharmaceutical (Group) have formed a joint venture (JV) to research, develop, manufacture and sell innovative, robotic-assisted catheter-based medical devices.
Diagnostics > In Vitro Diagnostics > News
Cepheid, Novacyt partner to distribute HPV diagnostic system in Latin America
By MDBR Staff Writer
Molecular diagnostics firm Cepheid has entered into a three year and non-exclusive agreement with Novacyt to distribute a complete Human Papillomavirus (HPV) diagnostic system in Latin America.
Diagnostics > In Vitro Diagnostics > News
ProAxsis gains CE mark approval for Active Neutrophil Elastase immunoassay
ProAxsis announced that it has successfully registered a CE Mark for its novel ProteaseTag Active Neutrophil Elastase Immunoassay.
Diagnostics > In Vitro Diagnostics > News
Agilent Technologies and Burning Rock sign agreement on molecular diagnostics
Agilent Technologies and Burning Rock announced they have signed an agreement under which Burning Rock will develop cancer diagnostics in China based on the Agilent SureSelect target enrichment system.
Diagnostics > In Vitro Diagnostics > News
Roche’s Harmony prenatal test wins CE mark approval
By MDBR Staff Writer
Roche has secured CE mark approval for its Harmony prenatal test to assess the probability of Down syndrome (Trisomy 21) and other chromosomal disorders.
Diagnostics > In Vitro Diagnostics > News
226-240 of 2977 results